These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12967788)

  • 1. Influence of immunosuppressive drugs on dendritic cells.
    Abe M; Thomson AW
    Transpl Immunol; 2003; 11(3-4):357-65. PubMed ID: 12967788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immunosuppressive drugs on dendritic cells and tolerance induction.
    Lagaraine C; Lebranchu Y
    Transplantation; 2003 May; 75(9 Suppl):37S-42S. PubMed ID: 12819489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs.
    Hackstein H; Thomson AW
    Nat Rev Immunol; 2004 Jan; 4(1):24-34. PubMed ID: 14704765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.
    Turnquist HR; Fischer RT; Thomson AW
    Methods Mol Biol; 2010; 595():135-48. PubMed ID: 19941109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro.
    Uss E; Yong SL; Hooibrink B; van Lier RA; ten Berge IJ
    Transplantation; 2007 Apr; 83(8):1098-106. PubMed ID: 17452901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dentritic cell derived IL-18 production is inhibited by rapamycin and sanglifehrin A, but not cyclosporine A.
    Ko H; Hambly BD; Eris JM; Levidiotis V; Wyburn K; Wu H; Chadban SJ; Yin JL
    Transpl Immunol; 2008 Nov; 20(1-2):99-105. PubMed ID: 18662782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
    Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J
    Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoids and their effect on dendritic cell function].
    Rozková D; Horváth R; Bartůnková J; Spísek R
    Cas Lek Cesk; 2005; 144(12):825-31; discussion 832. PubMed ID: 16389756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
    Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
    Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation.
    Barten MJ; Garbade J; Bittner HB; Fiedler M; Dhein S; Thiery J; Mohr FW; Gummert JF
    Int Immunopharmacol; 2006 Dec; 6(13-14):2011-7. PubMed ID: 17161355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing dendritic cells for the induction of transplantation tolerance.
    Silk KM; Fairchild PJ
    Curr Opin Organ Transplant; 2009 Aug; 14(4):344-50. PubMed ID: 19417656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the mammalian target of rapamycin and transplant tolerance.
    Bestard O; Cruzado JM; Grinyó JM
    Transplantation; 2009 Apr; 87(8 Suppl):S27-9. PubMed ID: 19384184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
    van Kooten C; Stax AS; Woltman AM; Gelderman KA
    Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present and future of immunosuppressive therapy].
    Eugui EM
    Medicina (B Aires); 2000; 60(1):67-80. PubMed ID: 10835702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-regulatory cells-what relationship with immunosuppressive agents?
    Wekerle T
    Transplant Proc; 2008 Dec; 40(10 Suppl):S13-6. PubMed ID: 19100898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.
    Fedoric B; Krishnan R
    Immunol Lett; 2008 Oct; 120(1-2):49-56. PubMed ID: 18652845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.